Remove Cannabis Remove DEA Remove Patients Remove State Laws
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 166
article thumbnail

Is The DEA Poised To Regulate Telepharmacy?

Cannabis Law Report

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alabama: Medical cannabis draft rules for physicians and patients released for public comment

Cannabis Law Report

he Alabama State Board of Medical Examiners Thursday announced draft rules to govern how physicians can recommend medical cannabis to eligible patients. complete a 4-hour continuing medical education course on medical cannabis and pass an examination. refer patients to a specific medical cannabis dispensary.

article thumbnail

Emerge Law Group (OR): PSILOCYBIN THERAPY FOR PATIENTS WITH ADVANCED ILLNESS IN OREGON

Cannabis Law Report

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Oregon’s Psilocybin Services Act (“PSA”), adopted via initiative in November 2020, makes therapeutic use of psilocybin legal under Oregon state law.

Therapy 52
article thumbnail

Constitutionality of Cannabis: Federal Lawsuit Against DEA, DOJ Proceeds

Marijuana Lawyer Blog

As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40
article thumbnail

What is the Difference Between a Cannabis Recommendation and Cannabis Prescription

United Patients Group

Introduction A cannabis ‘prescription’ is written by a doctor to be dispensed at a pharmacy (i.e. A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal.

DEA 52
article thumbnail

How to Talk To Your Doctor About Becoming a Legal Medical Cannabis Patient

MedicalJane

At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Of those, nine states and DC have went a step further and legalized marijuana for all adults 21 and over. Do you qualify for medical cannabis?